Clinical Therapeutic Effect Of Combination Of Syndrome Differentiation Depending Treatment And Chemotherapy On Non-Small-cell Lung Cancer At â…¢B/â…£ Stage

Background:Lung cancer,included 80 percent of non-small cell lung cancer (NSCLC),is currently the world's cancer the leading cause of death and on the rise.in NSCLC patients,nearly 70 percent of the patients at the time of diagnosis has been advanced(HIB-Ⅳstage).The therapy of Modern medicine onⅢB-Ⅳstage,is palliative,one of which the most important is chemotherapy playing in the integrated treatment of a important position.Is to platinum-based drug combined with chemotherapy is the standard chemotherapy in advanced stage,especially the third generation of chemotherapy drugs available,Such as Taxol(TAX),vinorelbine(NVB),gemcitabine(GEM), docetaxel(DOC),HCPT(CPT),and Alimta,which makes further improve the efficacy of the drug.Iressa and tarceva as the advent of molecular targeted drugs for the treatment of lung cancer provides a new direction.But a long time,chemotherapy for the treatment of NSCLC result is not satisfactory. Non-cytotoxic drug research gradually attracted people's attention, traditional Chinese medicine as a therapy of advanced lung cancer research is important.Objective:To explore the superiority and its links of treatment of Chinese drugs for advanced non-small-cell lung cancer(NSCLC).Methods:Restrospective research of 150 cases of advanced NSCLC treated with integrated treatment of Chinese medicine and western medicine and 120 cases with simple western medicine were carried out,according to two groups of patients with medical records truthfully filled out a unified design developed by researchers of the "advanced non-small cell lung cancer patients retrospective study questionnaire" Its contents include used by chemotherapy patients(including the completion of treatment)and treatment(including the near-and long-term effect indicators).In addition,the combination of Chinese and Western Medicine Group also recorded by intravenous preparation of Chinese medicine,oral proprietary Chinese medicine of the name,dosage and usage; decoction of Chinese medicine used by the legislative and prescriptions,and so on.Results of all the data used SPSS13.0 statistical software for analysis. According to count the different measurement data,choose the appropriate test methods.Results:Integrative Medicine in the group and the group were purely Western medicine into 150 cases and 120 patients,treatment before the two groups by gender,KPS,were to compare age and the KPS slightly dominant group only Western medicine.In the age and physical condition not in a dominant situation, there is no significant difference in cases of the complete relief(CR)plus partial relief(PR)and no-change(NC),the median survival duration and the time to progression(TTP)in both groups(P＞0.05),but on the tumor control the group f integrated treatment of Chinese and western medicine is with a higher rate higher.KPS and the situation in weight before and after treatment,the combined group of the integrated treatment of Chinese and Western Medicine is better than the simple Western medicine group,prompted in Integrative Medicine Group in improving the quality of life advantage.Conclusion:The integrated treatment of Chinese and western medicine for advanced non- small cell lung cancer has a certain superiority in stabilizing foci and quality of life,improving clinical symptoms,and prolonging lifetime and so on.In advanced non-small cell lung cancer treatment,combining Chinese and Western Medicine for a future development direction,and in particular to improve the quality of life of patients with respect.